Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Gross Profit (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Gross Profit for 16 consecutive years, with $21.7 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 19.27% to $21.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $83.2 million through Dec 2025, up 35.08% year-over-year, with the annual reading at $83.2 million for FY2025, 35.08% up from the prior year.
  • Gross Profit for Q4 2025 was $21.7 million at Niagen Bioscience, down from $21.9 million in the prior quarter.
  • The five-year high for Gross Profit was $21.9 million in Q3 2025, with the low at $9.2 million in Q1 2021.
  • Average Gross Profit over 5 years is $14.0 million, with a median of $12.6 million recorded in 2023.
  • The sharpest move saw Gross Profit fell 7.1% in 2022, then skyrocketed 47.71% in 2025.
  • Over 5 years, Gross Profit stood at $10.9 million in 2021, then rose by 10.56% to $12.0 million in 2022, then increased by 7.66% to $12.9 million in 2023, then surged by 40.66% to $18.2 million in 2024, then increased by 19.27% to $21.7 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $21.7 million, $21.9 million, and $20.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.